#VisualAbstract: Low-molecular-weight heparin does not improve live birth rates in women with recurrent pregnancy loss and thrombophilia
Bookmark 1. Live birth rate between the low-molecular-weight heparin and standard care group was...
Read MoreJul 29, 2023
Bookmark 1. Live birth rate between the low-molecular-weight heparin and standard care group was...
Read MoreJul 28, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 28, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 28, 2023
Bookmark 1. In this randomized controlled trial, the E-MOTIVE bundle, consisting of early...
Read MoreJul 25, 2023
Bookmark 1. Patients assigned to hemodynamic monitoring reported improved quality of life than...
Read MoreJul 21, 2023
Bookmark 1. In this randomized controlled trial, cyclophosphamide-tacrolimus-mycophenolate...
Read MoreJul 21, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 21, 2023
Bookmark 1. In the randomized controlled trial, dolutegravir treatment was noninferior to a...
Read MoreJul 20, 2023
Bookmark 1. Butylphthalide is effective — the BAST trial showed that butylphthalide is associated...
Read MoreJul 16, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article...
Read MoreJul 16, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No...
Read MoreJul 16, 2023
Bookmark 1. The ARAMIS trial revealed that the rate of favourable neurologic function at 90 days was 93.8% among patients assigned to dual antiplatelet therapy (DAPT) compared to those assigned to intravenous alteplase at 91.4%....
Read MoreJul 8, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 8, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 8, 2023
Bookmark 1. All-cause and cardiovascular mortality rates were greater in the 24h systolic blood...
Read MoreJul 8, 2023
Bookmark 1. In this randomized controlled trial, the NmCV-5 vaccine elicited an immune response...
Read MoreJul 8, 2023
Bookmark 1. In this randomized controlled trial, patients who received transcatheter repair of...
Read MoreJul 8, 2023
Bookmark1. Patients assigned to immediate tonsillectomy had significantly fewer sore throat days...
Read MoreJul 2, 2023
Bookmark 1. In this randomized controlled trial, the treatment of gestational diabetes before 20...
Read MoreJul 2, 2023
Bookmark 1. For patients with IgA nephropathy (IgAN), long-term use of hydroxychloroquine...
Read More